Bortezomib

Catalog #
27028
$150 *
Size: 10 mg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Potent (Ki, 0.6 nM), specific and reversible proteasome inhibitor; no significant inhibitory activity against other enzymes or receptors. Bortezomib inhibits cell proliferation of H460 cells (human non-small cell lung cancer cell lines) with an IC50 of 0.1 µM and has been associated with suppresion of prostate cancer cell lines with an IC90 of 10 nM.

Synonyms
Velcade, MG-341, PS-341
Product Info
Storage and Usage
Citations
Purity

≥99%

Format
White to off-white solid.
Formula
C19H25BN4O4
MW
384.2 Da
Solubility
Soluble in DMSO at 200 mg/ml; soluble in ethanol at 200 mg/ml; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-10 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
CAS Registry #
179324-69-7
References
1. Bouchard, PR., et al. 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) & 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP (Eds.) (2004).
2. Ling, Y., et al. Clin. Cancer Res. 9: 1145-1154 (2003).
3. Williams, S., et al. Mol. Cancer Ther. 2: 835-843 (2003).